Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibody and Peptide Therapeutics

John Watson's Biography



John Watson, Director, Promega Corporation

Dr. Watson has a B.S. in Genetics and Cell Biology from the University of Minnesota, an M.S. in Bacteriology; and a Ph.D. in Biomolecular Chemistry from the University of Wisconsin. After a clinical postdoctoral fellowship in Clinical Chemistry and Molecular Diagnostics he became Director of Molecular Diagnostics at Epicentre Technologies where he led R&D and Marketing efforts for their clinical products. Subsequent positions have included Director of Cellular Analysis at Promega Corporation, and Director of Marketing for the PanVera division Vertex Pharmaceuticals (becoming Director of Marketing for Drug Screening at Invitrogen after the acquisition). He also managed R&D, applications and Marketing for the FTIR instrument division of Thermo Electron Corporation.

John Watson Image

Molecular Characterization of Biopharmaceutical Processes Using Luminescent Technologies: Applications in Biologics Discovery, Bioreactor Monitoring, and QA/QC Testing

Wednesday, 20 July 2011 at 16:00

Add to Calendar ▼2011-07-20 16:00:002011-07-20 17:00:00Europe/LondonMolecular Characterization of Biopharmaceutical Processes Using Luminescent Technologies: Applications in Biologics Discovery, Bioreactor Monitoring, and QA/QC TestingSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2011-07-20 00:00:002011-07-21 00:00:00Europe/LondonAntibody and Peptide TherapeuticsSELECTBIOenquiries@selectbiosciences.com